Novo Holdings Milestone Pharmaceuticals Inc. Transaction History

Novo Holdings

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$5.86 - $9.43 $3.11 Million - $5 Million	-530,003 Reduced 20.95%	2,000,000 $18.4 Million
Q1 2022 May 16, 2022	SELL	$4.1 - $8.24 $2,386 - $4,795	-582 Reduced 0.02%	2,530,003 $16.2 Million
Q4 2020 Feb 16, 2021	BUY	$5.57 - $7.66 $2.51 Million - $3.45 Million	450,000 Added 21.63%	2,530,585 $17 Million
Q1 2020 May 15, 2020	SELL	$1.7 - $22.5 $601,604 - $7.96 Million	-353,885 Reduced 14.54%	2,080,585 $3.83 Million
Q4 2019 Feb 14, 2020	SELL	$15.4 - $21.9 $3.7 Million - $5.26 Million	-240,000 Reduced 8.97%	2,434,470 $39 Million
Q2 2019 Aug 14, 2019	BUY	$15.37 - $27.15 $41.1 Million - $72.6 Million	2,674,470 New	2,674,470 $72.6 Million

28.7M

200

Ticker MIST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,010,900
Market Cap $70.8M
Description
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

Stay updated on Novo Holdings with notifications on news.